Diligence memo · auto-generated · as of July 2, 2026

Nitinol Devices & Components, Inc.

Nitinol Devices & Components, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Nitinol Devices & Components, Inc. operates in Other Health Care, based in FREMONT.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Nitinol Devices & Components, Inc. has raised $56M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $56M on 2016-08-08.

Most recent recorded round closed around 2016-08-08.

Valuation (modeled)modeled

Provath models Nitinol Devices & Components, Inc. at approximately $1.3B (range $203M–$3.4B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.23× the median modeled value of Series C Other Health Care companies in 2016–2018 (40 peers) — value vs value, same stage and era. Within the normal band (123% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 9.9 yr ago; this sector typically re-raises about every 14 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 93% of Other Health Care peers (5377 compared).

Modeled value ranks above 98% of those peers.

Closest niche peers: Specialty Networks, LLC, New MMI Holdings, Inc., BioMatrix Holdings, L.L.C., Sea Hunter Holdings, LLC, Bind Benefits, Inc..

Peoplefiled

6 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.